An affinity labeling reagent for the estrogenic-binding site of bovine liver L-glutamate dehydrogenase (EC 1.4.1.3) was prepared by conversion of diethylstilbestrol to its alkylating analogue, bromoacetyldiethylstilbestrol. Under standard assay conditions, the analogue acted as a reversible allosteric ligand with regulatory activity much like that of diethylstilbestrol. However, incubation of the enzyme with the alkylating agent in the presence of DPNH resulted in a permanent decrease in glutamate (X form) and an increase in alanine (Y form) activities, and in covalent attachment of diethylstilbestrol in the ratio of 1 mol per subunit (of particle weight 52,000 Preliminary studies with various DES derivatives indicated that one of the two hydroxyl groups can be modified by acetylation without loss of the capacity to bind to GDH. This observation prompted us to attach a bromoacetyl group to one of the hydroxyl groups of the DES molecule. The close structural analogy between bromoacetyl and acetyl DES led us to the expectation that a reversible ligand-protein interaction should produce a reversible allosteric effect, and that such a complex could be induced to form a covalent bond (by elimination of bromoacetic acid) and attach the DES molecule to the protein. 
Estrogenic hormones alter the structure and the catalytic activity of crystalline glutamate dehydrogenase (EC 1.4.1.3) (GDH); they simultaneously inhibit glutamate and stimulate alanine dehydrogenase activity of the enzyme (1) (2) (3) . ADP can reverse the effect of these steroids (4) . The action of regulatory molecules, such as diethylstilbestrol (DES), GTP, and ADP, is explained by a shift of the equilibrium between two different forms (X=Y) of the enzyme. The X form possesses high glutamate activity; the Y form possesses alanine dehydrogenase activity. Estrogen and GTP favor the Y form, while ADP shifts the equilibrium to the X form. Such behavior has been rationalized in terms of allosteric interaction by Monod et al. (5) and Koshland (6) ; the term allosteric is now generally employed in connection with regulatory effects that are due to conformational changes in the protein molecule induced by a ligand (7, 8) . The precise molecular mechanism by which the allosteric ligand acts remains obscure. Clearly, more specific information is needed about the chemistry of the regulatory and active sites before allosteric regulation is understood.
During the past several years we have been engaged in a systematic chemical study of The reactions were started by the addition of the enzyme; 2-min incubations were used for calculations of enzymatic activity.
GDH activity was measured, in the direction of a-ketoglutarate reductive amination, with a solution containing 1 ml Chemical reaction of GDH with BADES GDH (0.3 mg) was incubated in 1 ml of a reaction mixture containing 0.05 M phosphate buffer (pH 7.6), 5 X 10-5 M BADES, and 1 X 10-3 M DPNH at room temperature. The rate of irreversible inhibition was determined by assay of aliquots. The reaction was terminated by gel filtration through a Sephadex G-25 column (1.5 X 40 cm); the product was eluted with 0.05 M phosphate buffer (pH 7.6). Preparation of [SH]DES-GDH GDH (6 mg) was incubated in a 10-ml reaction mixture containing 0.05 M phosphate (pH 7.6), 8 X 10-5M bromoacetyl-['H]DES (536,000 cpm/mg), and 1 X 10-3 M DPNH: after 2 hr of incubation, an aliquot (5 ml) of the reaction mixture was passed through a Sephadex G-25 (fine) column (2.5 X 40 cm) to remove the excess reagent. For counting, an aliquot (1 ml) of modified protein was mixed with 10 ml of Bray's solution and counted. Another aliquot (2 ml) of modified protein was precipitated with 4 ml of trichloroacetic acid (30%), then centrifuged at 5000 rpm for 15 min. The precipitate was washed four times with absolute alcohol and once with ether. GDH (0.3 mg/ml) was incubated in phosphate buffer (0.05 M, pH 7.6) with 5 X 10-5 M [3H]BADES in the presence of 1 X 10-3 M DPNH. Aliquots were taken at various time intervals and passed through a Sephadex G-25 column, and the glutamate and alanine activities and the radioactivity were determined.
filtered, evaporated to dryness, and dissolved in 1 ml of toluene, and the radioactivity was determined.
RESULTS AND DISCUSSION
The reversible BADES-enzyme interaction
The reversible allosteric effect of BADES (added to the enzyme without incubation with DPNH) was examined by determining the glutamate and alanine dehydrogenase activities of the enzyme (Fig. 1) . Clearly, BADES, like DES itself, stimulates alanine and inhibits glutamate activity and behaves as a reversible allosteric ligand. Note that the stimulatory and the inhibitory effects were reciprocal, as has been previously observed for other GDH effectors such as ADP and GTP. The interaction between BADES and GDH, under standard assay conditions, appears to be a reversible one. This conclusion was based on the following observations: (a) Dilution of the assay mixture with bovine serum albumin solution resulted in complete recovery of glutamate activity (9) 
. (b)
When the assay was performed with [3 H]BADES, there was no significant radioactivity incorporated into the protein after Sephadex filtration or trichloroacetic acid precipitation (to be published). These results indicate that the enzyme responds identically to BADES and DES; furthermore, the interaction is reversible. The most reasonable explanation is that BADES and DES exert their effect by shifting the equilibrium from the X (glutamate) to the Y (alanine) form. The structure and the catalytic activity of the enzyme are rapidly altered by its interaction with the ligand without any apparent chemical alteration in the protein.
Chemical reaction of GDH with BADES
We turn our attention to the next question, the irreversible effect of BADES on GDH. The enzyme was incubated with BADES, and the progress of the reaction was followed by removing aliquots, passing them through a Sephadex G-25 column, and measuring the analine and glutamate activities of the modified protein (Fig. 2) . There was a progressive loss of glutamate activity to about 80% inhibition in the first 1.5 hr, and a slight activation of the alanine activity. This modification appears to be an irreversible one, since attempts to restore native activity by extensive dialysis against 0.05 M phosphate buffer or gel-filtration through Sephadex G-25 were not successful. These results indicate that a covalent bond with DES has been formed at the estrogen-binding site of the enzyme. To substantiate this conclusion, and to quantitate the incorporation into protein, we performed the reaction with bromoacetyl-['HIDES ( Table 2 .
DES-GDH was examined by acrylamide gel electrophoresis and was found to be a single component. The DES-GDH derivative was purified by affinity chromatography (manuscript in preparation) on DES-Sepharose (a column of Sepharose conjugated with DES). By this technique, it was possible to separate an unretarded peak (88%) containing the modified protein (and all the radioactivity) from a second component, which showed much stronger UV absorption than the DESSepharose that contained native enzyme. These techniques demonstrated that the reaction of BADES with GDH was specific and stoichiometric.
Since DES is probably attached to the protein by a carboxylic ester linkage, we expected that such a bond would be stable at neutral pH, but easily cleaved by mild alkaline treatment or by exposure to nucleophilic reagents such as hydroxylamine. This was found to be true (Table 3) . However, it was impossible to regenerate enzyme activity (glutamate assay) after the displacement of DES by hydroxylamine.
The results of the affinity-labeling experiments are as follows. (a) We have definite evidence for the covalent attachment of DES to the protein; the stoichiometric ratio was approximately 1 mol of DES per subunit. (b) The inactivation of glutamate, but the retention of analine, activity of the enzyme by BADES is compatible with the conclusion that this compound acts as an affinity label that mimics DES. (c) A reasonable conclusion is that the covalently bound DES acts similarly to the noncovalently bound DES.
Direct and indirect protection against the BADES reaction
To explore the mechanism of BADES reaction, we examined two methods of protecting the enzyme against modification by BADES. Substrate analogues are known to protect the active site of an enzyme against chemical modification. Therefore, Aliquots were taken after a period of 30 min. passed through Sephadex G-25, and assayed for glutamate activity.
DES should protect the enzyme against the BADES reaction. Also, in the case of an allosteric enzyme, there is an alternative possibility to control chemical modification at the estrogenbinding site, based on the following assumption: the Y form of the enzyme has an affinity for the estrogen molecule while the X state does not. This line of reasoning leads to the idea that an effector that will shift the equilibrium into the X form will prevent chemical modification at the estrogen-binding site. ADP is known to put GDH into the X form and, thus, reverse the action of the steroid (4). Thus, we would expect that both DES and ADP should protect the enzyme against reaction with BADES, DES directly by competition for the same site and ADP indirectly by a conformational shift in the protein.
The results (Table 4) tend to confirm our predictions; both ADP and DES protect against the BADES reaction, as shown by glutamate activity and the incorporation of radioactivity into the protein.
Conformational freezing
Can the enzyme be frozen into a given conformation as a result of the covalent attachment of DES? The response of the modified enzyme to effectors such as ADP and GTP is shown in Table 5 . The DES-GDH did not respond to allosteric effectors such as ADP and GTP. These results indicate that modification with BADES desensitizes the enzyme to effectors such as ADP and GTP. We have not examined whether the actual affinity of the enzyme for these effectors has been altered. Desensitization is one of the interesting characteristics of allosteric enzymes; this term refers to the loss of the regulatory, but not the catalytic, function. Recently, we have observed that covalent attachment of a pyruvate group to the alanine site of GDH resulted in a loss of the regulatory response to ADP and GTP. It has also been reported that treatment of GDH with mercury resulted in desensitization to various effectors (10) . To explain this effect, it was suggested that the change in structure of the enzyme induced by mercury may interfere with the binding of regulatory molecules. Colman and Frieden (11) studied the effect of acetylation of GDH; they reported a loss of enzyme activity and extensive desensitization to GTP. Our results are consistent with the assertion that the covalent attachment of DES to GDH produces a permanent shift of the equilibrium from the X to the Y state, i.e., conformational freezing of the protein in the Y form. This covalent attachment appears to freeze the enzyme in a conformation that mimics the noncovalent DES -protein state. There are several examples of enzyme-catalyzed modifications, by covalent mechanisms, that regulate enzyme activity. The classical ones are the regulation of glycogen phosphorylase (12) in mammalian tissues and the regulation of glutamine synthetase of E. coli by adenylation (13 
